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Genome-wide association study in almost  
195,000 individuals identifies 50 previously  
unidentified genetic loci for eye color
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Human eye color is highly heritable, but its genetic architecture is not yet fully understood. We report the results 
of the largest genome-wide association study for eye color to date, involving up to 192,986 European participants 
from 10 populations. We identify 124 independent associations arising from 61 discrete genomic regions, including 
50 previously unidentified. We find evidence for genes involved in melanin pigmentation, but we also find associ-
ations with genes involved in iris morphology and structure. Further analyses in 1636 Asian participants from two 
populations suggest that iris pigmentation variation in Asians is genetically similar to Europeans, albeit with smaller 
effect sizes. Our findings collectively explain 53.2% (95% confidence interval, 45.4 to 61.0%) of eye color variation 
using common single-nucleotide polymorphisms. Overall, our study outcomes demonstrate that the genetic com-
plexity of human eye color considerably exceeds previous knowledge and expectations, highlighting eye color as 
a genetically highly complex human trait.
INTRODUCTION
Eye color is primarily determined by melanin abundance within the 
iris pigment epithelium, which is greater in brown than in blue eyes 
(1), and both the density and distribution of stromal melanocyte 
cells (2). Ratios of the two forms of melanin, eumelanin and pheo­
melanin, within the iris as well as light absorption and scattering by 
extracellular components (Tyndall scattering) are additional factors 
that give irises their color (3). Absolute melanin quantity and the 
eumelanin:pheomelanin ratio are higher in brown irises (4), while 
blue or green irises have very little of both pigments and relatively 
more pheomelanin.
European populations, or those with partial European origin, 
display the largest diversity of iris color, varying from the lightest 
blue to darkest brown. The prevalence of blue eyes correlates with 
geographic latitude across Europe and neighboring areas (5), likely 
as a result of human migration, sexual, and possibly natural selec­
tion (6–8). Similarly, eye color variation with varying degrees of brown 
irises is seen in Asian populations (9), although with a much reduced 
range compared to brown eye color variation in Europeans.
Iris color is highly heritable (10). Previous genome­wide associ­
ation studies (GWASs) have identified various single­nucleotide poly­
morphisms (SNPs) in and around 10 genes significantly associated 
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with eye color (11–14), highlighting the polygenic nature of a trait 
that, in the past, was assumed to be genetically simple (15). The 
strongest genetic influence on eye color is exerted by the neighboring 
HERC2 and OCA2 genes (13, 14, 16, 17), where a long distance en­
hancer effect of an intronic SNP in HERC2 was demonstrated inter­
acting with the OCA2 promoter functioning as a molecular switch 
between light and dark pigmentation (18). Previously available ge­
netic knowledge allows accurate prediction of blue and brown eye 
color, for instance, with a DNA test system based on six SNPs from 
six genes, including HERC2 and OCA2 (19), that has been used in 
anthropological (20) and forensic (21, 22) applications. However, 
nonblue and nonbrown eye color can be genetically predicted with 
considerably lower accuracy (19, 21, 22), likely because of unknown 
predictive SNPs and responsible genes. Moreover, the phenotypic 
variance of eye color not previously explained by GWASs ranged 
between 26% for a blue versus a brown scale (10) and 50% for a scale 
using three categories (11) across studies. This illustrates the likely 
presence of yet unknown genes responsible for the noted missing 
genetic predicting accuracy (19, 21, 22) and missing heritability of 
human eye color (23).
To overcome these limitations and better understand the genetics 
of human eye color, we carried out the largest eye color GWAS to 
date. Our study involved 157,485 individuals of European ancestry 
in the discovery stage and an additional 35,501 ancestral European 
individuals in the replication stage, as well as 1636 Asians (of Han 
Chinese and Indian ancestry) additionally used for replication pur­
poses, in total 194,622 individuals of different ancestries.
RESULTS
Linear regression results were obtained for 11,532,091 SNPs from 
157,485 individuals of European ancestry in the discovery dataset 
from the personal genetics company 23andMe Inc. The Devlin’s 
genomic factor (24) was  = 1.13, while a linkage disequilibrium 
(LD) score regression intercept of 1.095 with an [(intercept − 1)/
(mean(2) − 1)] ratio of 0.19 was obtained, which is consistent with 
expectations based on the large sample size and polygenic architec­
ture (25). In total, 12,192 SNPs were associated at genome­wide 
significance (P < 5 × 10−8) with eye color. These SNPs clustered 
in 52 distinct genomic regions, 50 across the autosomes and 2 
on chromosome X (Table 1 and Fig. 1). While confirming the 
10 genomic regions previously associated with human eye color 
(11, 26, 27), the remaining 42 genomic regions identified represent 
novel discoveries.
As expected, many of the strongest associations were observed 
for SNPs within HERC2 (rs1129038, P < 10−330), the strongest eye 
color–associated region known previously, and genes involved in 
five of the seven known types of oculocutaneous albinism (OCA): 
OCA1 (TYR, rs1126809, P = 1.8 × 10−255), OCA2 (OCA2, rs1800407, 
P < 10−330), OCA3 (TYRP1, rs13297008; P = 5.0 × 10−250), OCA4 
(SLC45A2, rs16891982; P = 2.0 × 10−255), and OCA6 (SLC24A5, 
rs1426654; P = 2.7 × 10−26). HERC2, TYR, OCA2, TYRP1, and SLC45A2 
have previously been associated with eye color (13, 14, 16, 17, 19), 
while previous studies found association with hair and skin pig­
mentation for SLC24A5 (27) and eye color in a South Asian popula­
tion (28), but not with eye color in Europeans as we showed here. 
No significant eye color associations were found for either the OCA5 
(the 4q24 region) or the OCA7 (C10ORF11) locus, the other two 
genes involved in OCA, in our large discovery sample; however, 
C10ORF11 has recently been associated with human eyebrow color 
(29). The remaining four previously reported loci (11) were also 
strongly associated with eye color in the present study: LYST 
(rs2385028, P = 2.4 × 10−12), IRF4 (rs12203592, P = 1.6 × 10−321), 
SLC24A4 (rs17184180, P = 1.3 × 10−284), TSPAN10 (previously re­
ported as NPLOC4, rs6420484; P = 7.5 × 10−90), and TTC3 (rs2835660, 
P = 1.6 × 10−17).
Among the 41 novel genetic loci identified in our discovery anal­
ysis, we detected significant eye color association for SNPs within 
TPCN2 (rs72928978, P = 6.42 × 10−32) and MITF (rs75114713, 
P = 8.11 × 10−24). These two genetic loci and five others (near the 
DTL, AP3M2, SOX5, DCT, and SIK1 genes; Table 1) were associated 
with hair and skin pigmentation in previous GWASs (highlighted 
with asterisk in Table 1) (27, 30–32), while their eye color associa­
tion is reported here. A comparison of our results with those from 
the GWAS Catalog (33) revealed that 34 (81%) of the 41 novel eye 
color–associated loci are unique to eye color and not shared with 
other pigmentation traits (Table 1), which is 36 (69%) when consid­
ering all 52 eye color–associated loci we identified here including the 
11 previously known loci. The unique novel eye color loci include 
SNPs in TRAF3IP1 (rs74409360, P = 8.1 × 10−20) and SEMA3A 
(rs6944702, P = 1.7 × 10−10). TRAF3IP1 has been previously associ­
ated with iris furrows, while SEMA3A was associated with iris crypt 
variation (3). These findings suggest that eye color may, at least in 
part considered by the eye color phenotyping done here, be mediated 
through structural effects within the iris. Significant association was 
also observed for SNPs within HIVEP3 (rs6696511, P = 1.3 × 10−45), 
which was previously associated with refractive error and myopia 
(34). Novel eye color association within PPARGC1A (rs4521336, 
P = 1.3 × 10−9) and within MAP2K6 (rs3809761, P = 5.1 × 10−9) 
likely arises from their participation in pigmentation pathways, the 
PGC1­ protein, the product of the PPARGC1A gene. PGC1­ ac­
tivates the MITF promoter (35) acting as a regulator in the pigment 
pathway of the tanning response, while overexpression of MAP2K6 
increases melanocyte dendricity (36), allowing greater transportation 
of melanosomes. We report here eye color associations for genetic 
loci located on the X chromosome. DNA variants clustering around 
the SSX1 (rs78542430, P = 5.93 × 10−53) and TMEM255A (rs5957354, 
P = 5.43 × 10−23) genes were significantly associated with eye color. 
Little is published about the TMEM255A and SSX1 genes and their 
potential functional roles relating to the eye, and further studies are 
required to understand the role of these genes in iris pigmentation. 
Notably, a recently published large GWAS on hair color in Europeans 
was the first to discover X­chromosomal loci to be involved in hu­
man pigmentation (31), albeit with another gene (COL46A, 12 Mbp 
upstream from nearest associated locus in our study) than we found 
to be associated with eye color here. Notably, SNPs in or near the 
MC1R gene, known to be involved in light skin and red hair color, 
did not show eye color association in our study.
Next, we conducted a conditional analysis to identify SNPs asso­
ciated with eye color after adjusting for the effect of the main asso­
ciation signal at a respective locus. This analysis highlighted 115 
conditionally associated SNPs distributed across the novel and pre­
viously known 52 genomic regions (table ST1; a secondary list of 
489 high­quality control (QC) scoring, significantly associated SNPs 
is provided in table ST2) that improve the phenotypic variability 
explained by genetic factors compared to the lead SNPs. Of the 
115 independently associated SNPs, 9 were missense mutations 
(table ST3) (37), which may suggest their causal role.
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Table 1. Strongest associated SNPs from the 52 genomic regions independently associated with eye color in the European discovery cohort 
(N = 157,485). A full list of 115 independently associated SNPs from conditional analysis at these loci can be found in table ST1. SNPs with novel associations for 
eye color identified here are highlighted in bold. SNPs that were associated with other pigmentation traits, but not iris color, in previous studies are indicated by 
an asterisk (*). Chr is the chromosome for the given SNP, genome position (Pos) refer to the HG build 37, RS is the rsid for the given SNP, Freq is the allele 
frequency of the stated reference allele, Beta is the effect size for the stated reference allele, SE is the respective standard error for the beta, Alt allele is the 
alternative allele for the given SNP, and N is the sample size tested for the respective SNP. 
Region Chr Pos RS Nearest gene Ref allele Alt allele N Freq Beta SE P
1 1 9166344 rs6693258 GPR157 T C 157483 0.216 −0.056 0.0091 9.86 × 10−10
2 1 42110888 rs6696511 HIVEP3 T C 157483 0.382 0.109 0.0077 1.35 × 10−45
3 1 212421629 rs351385 *DTL G A 157483 0.580 −0.083 0.0075 2.31 × 10−28
4 1 236035805 rs2385028 LYST T C 157483 0.245 0.061 0.0086 2.43 × 10−12
5 2 46233381 rs13016869 PRKCE G C 157483 0.208 −0.058 0.0092 2.23 × 10−10
6 2 206950236 rs112747614 INO80D G C 157483 0.696 0.054 0.0081 3.69 × 10−11
7 2 219755011 rs121908120 WNT10A T A 157483 0.976 0.140 0.0247 1.54 × 10−8
8 2 223483670 rs12614022 FARSB G A 157483 0.636 0.048 0.0078 4.26 × 10−10
9 2 239276278 rs74409360 TRAF3IP1 T C 157483 0.076 −0.128 0.0140 8.09 × 10−20
10 3 42762488 rs3912104 CCDC13 T A 157483 0.541 0.045 0.0075 1.47 × 10−9
11 3 69980177 rs116359091 *MITF G A 157483 0.974 −0.229 0.0246 1.02 × 10−20
12 4 23939399 rs4521336 PPARGC1A T C 157483 0.359 0.048 0.0079 1.28 × 10−9
13 4 59359559 rs141318671 No gene G A 157483 0.993 −0.318 0.0568 2.09 × 10−8
14 4 90059434 rs6828137 TIGD2 T G 157483 0.457 −0.041 0.0075 3.93 × 10−8
15 5 311902 rs62330021 PDCD6, AHRR G A 157483 0.948 −0.325 0.0171 1.36 × 10−80
16 5 33951693 rs16891982 *SLC45A2 G C 157483 0.958 −0.654 0.0191 1.97 × 10−255
17 5 40273518 rs348613 DAB2 G A 157483 0.001 0.731 0.1227 2.54 × 10−9
18 5 123896988 rs72777200 ZNF608 T C 157483 0.828 0.074 0.0100 1.22 × 10−13
19 5 148216187 rs11957757 ADRB2 G A 157483 0.547 0.042 0.0075 2.94 × 10−8
20 6 396321 rs12203592 *IRF4 T C 157483 0.171 −0.385 0.0100 1.61 × 10−321
21 6 10538183 rs6910861 GCNT2 G A 157483 0.461 0.078 0.0076 1.20 × 10−24
22 6 158841725 rs341147 TULP4 G A 157483 0.343 −0.045 0.0078 6.45 × 10−9
23 7 45960645 rs2854746 IGFBP3 G C 157483 0.587 −0.043 0.0076 1.24 × 10−8
24 7 83653553 rs6944702 SEMA3A T C 157483 0.512 0.048 0.0075 1.71 × 10−10
25 8 12690997 rs6997494 LONRF1 T G 157483 0.480 0.048 0.0074 1.07 × 10−10
26 8 42003663 rs12543326 *AP3M2 G A 157483 0.875 0.065 0.0113 9.07 × 10−9
27 8 81350433 rs147068120 ZBTB10 T C 157483 0.038 −0.122 0.0198 8.34 × 10−10
28 9 12677471 rs13297008 *TYRP1 G A 157483 0.388 0.260 0.0077 4.99 × 10−250
29 9 27366436 rs12552712 MOB3B T C 157483 0.604 −0.056 0.0077 2.79 × 10−13
30 9 132001056 rs12335410 IER5L T C 157483 0.221 −0.058 0.0090 1.28 × 10−10
31 11 68831364 rs72928978 *TPCN2 G A 157483 0.877 0.142 0.0121 6.42 × 10−32
32 11 89017961 rs1126809 *TYR G A 157483 0.721 0.285 0.0083 1.82 × 10−255
33 12 23979791 rs9971729 *SOX5 C A 157483 0.566 0.082 0.0076 5.03 × 10−27
34 12 92567833 rs790464 BTG1 T C 157483 0.189 0.060 0.0096 4.50 × 10−10
35 13 74178399 rs2095645 KLF12 G A 157483 0.672 0.050 0.0079 3.26 × 10−10
36 13 95189401 rs9301973 *DCT G A 157483 0.671 0.066 0.0080 1.48 × 10−16
37 14 69236136 rs138777265 ZFP36L1 C A 157483 0.047 −0.109 0.0176 6.21 × 10−10
38 14 92780387 rs17184180 *SLC24A4 T A 157483 0.567 0.271 0.0075 1.34 × 10−284
39 15 28211758 rs4778218 *OCA2 G A 157483 0.834 −0.520 0.0100 <1 × 10−330
40 15 28356859 rs1129038 *HERC2 T C 157483 0.734 −2.605 0.0058 <1 × 10−330
41 15 48426484 rs1426654 SLC24A5 G A 157483 0.102 0.684 0.0644 2.72 × 10−26
continued on next page
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Using additional independent data from 35,501 individuals of 
European ancestry enrolled in nine different studies collected by the 
International Visible Trait Genetics (VisiGen) Consortium and its 
study partners, we sought to replicate the findings from the discovery 
analysis. For this, we tested the strongest associated SNP for each of 
the 52 regions (lead SNPs) identified in the discovery GWAS. To 
minimize data fragmentation and therefore maximize statistical 
power, results of regression analyses from each of the nine VisiGen 
studies were meta­analyzed together, and the outcome of this 
meta­analysis was used to replicate the discovery stage findings. Be­
cause of the differences in sample size, genotyping platforms, and 
imputation methods across the VisiGen studies, several SNPs high­
lighted by the discovery GWAS were not available or did not pass 
quality control in the replication dataset, particularly variants of low 
minor allele frequency (MAF). Some VisiGen studies had no avail­
ability of X chromosome data. Therefore, replication was attempted 
for 48 lead SNPs from 50 autosomal regions highlighted in the dis­
covery analysis (table ST4). Overall, for 47 (98%) of the 48 lead SNPs, 
the direction of effect was the same in the replication analysis as 
previously seen in the discovery analysis (Fig. 2 and table ST4). For 
27 (56%) lead SNPs, we obtained significant replication after apply­
ing a strict Bonferroni adjustment for multiple testing (0.05/48 = 
1.04 × 10−3), including 18 (47%) of the 38 novel lead SNPs. An addi­
tional nine (24%) of the novel lead SNPs were associated at nominal 
(P < 0.05) significance. There was minimal heterogeneity between 
cohorts for these SNPs; a histogram of the heterogeneity I­scores is 
provided in fig. S1.
Results from both the discovery and replication studies were then 
meta­analyzed including a total of 192,986 Europeans from 10 pop­
ulations. The Devlin’s genomic factor was relatively unchanged in 
this analysis ( = 1.14). With the added statistical power, we found 
genome­wide significant associations for SNPs in an additional 
Fig. 1. Manhattan plot of eye color GWAS results in the European discovery cohort (N = 157,485). All results with P values <5 × 10−8 are indicated in red.
Region Chr Pos RS Nearest gene Ref allele Alt allele N Freq Beta SE P
42 16 1376386 rs761063 UBE2I G C 157483 0.277 −0.050 0.0084 2.07 × 10−9
43 17 1966889 rs4790309 SMG6 T C 157483 0.456 0.041 0.0075 3.71 × 10−8
44 17 67497367 rs3809761 MAP2K6 G A 157483 0.811 0.059 0.0101 5.08 × 10−9
45 17 79612397 rs6420484 *TSPAN10 G A 157483 0.645 −0.161 0.0080 7.53 × 10−90
46 19 7581625 rs73488486 ZNF358 T G 157483 0.097 0.086 0.0128 2.40 × 10−11
47 20 4948248 rs2748901 SLC23A2 G A 157483 0.463 −0.047 0.0075 3.37 × 10−10
48 21 38568882 rs2835660 TTC3 G C 157483 0.545 −0.064 0.0075 1.62 × 10−17
49 21 44783287 rs622330 *SIK1 G A 157483 0.512 0.111 0.0075 3.87 × 10−49
50 22 46369657 rs35051352 WNT7B G C 147875 0.549 −0.062 0.0081 3.33 × 10−14
51 23 48118832 rs78542430 SSX1 T A 157483 0.450 −0.095 0.0062 5.93 × 10−53
52 23 119439335 rs5957354 TMEM255A T A 157483 0.861 −0.090 0.0092 5.43 × 10−23
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nine separate genomic regions (table ST5). All nine genetic loci were 
novel, not previously associated with human eye color. Three of these, 
PDE4D (rs62370541, P = 5.8 × 10−9), JAZF1 (rs849142, 3.0 × 10−9), 
and SOX6 (rs2351061, P = 4.0 × 10−8), have recently been associated 
with hair color (31). PDE4D inhibitors have been shown to increase 
melanin pigment in the skin of mouse models (38), as PDE4D is a 
target of the melanin­stimulating hormone/cyclic adenosine mono­
phosphate (AMP)/melanocyte­inducing transcription factor (MITF) 
pathway (38).
Next, we compared results obtained from European subjects with 
association observations from a meta­analysis of 1636 Asian indi­
viduals (959 Han Chinese and 677 Indians from Singapore), for 
which quantitative measurements of the iris color were available 
(see the Supplementary Methods for information about quantitative 
phenotyping). Reliable SNP data were available for 44 of the lead 
autosomal SNPs from the 52 genetic loci identified by conditional 
analysis in the European discovery cohort. The remaining eight lead 
SNPs had a MAF smaller than 1% in this cohort and thus were ex­
cluded on account of the much smaller sample size. Thirty­one 
SNPs (70%) had the same direction of effect as the European 
analysis, and 5 (11%) of these 44 SNPs were significantly associ­
ated with eye color in Asians, after adjustment for multiple testing 
(Bonferroni­adjusted P value: 0.05/44 = 1.13 × 10−3). This included 
SNPs from two of the newly identified genes GPR157 (rs6693258, 
P = 3.6 × 10−5) and SIK1 (rs622330, P = 1.7 × 10−4) (table ST6), as well 
as from the previously known HERC2 gene (rs1129038, P = 2.2 × 10−4), 
which is the most strongly eye color–associated SNP in Europeans 
(17). For this marker, we observed considerable MAF differences 
between Europeans and Asians (T allele: 0.05 in Asians and 0.73 in 
Europeans). The strongest association in the Singaporean cohorts, 
however, was found within SLC24A5 (rs1426654, P = 1.9 × 10−7) 
representing the OCA type 6 (OCA6) locus. Notably, OCA6 was 
first reported in a Chinese family (39). However, the HERC2 and 
SLC24A5 SNPs were the only two variants to display heterogeneity 
between the two Singaporean cohorts (table ST6), with association 
primarily being driven by the cohort of South Asian ancestry. This 
is likely a due to South Asian and European populations being more 
closely related than East Asian and European populations. The MAFs 
for rs1426654 were considerably different between Asians (0.80 over­
all, 0.99 in East Asians, and 0.52 in South Asians) and Europeans 
(0.10) for the G allele, explaining why this SNP is often used as a 
DNA marker for biogeographic ancestry (40). Previously, SLC24A5 
rs1426654 not only explained a considerable proportion of the vari­


















Fig. 2. Comparison of SNP beta and Z scores between the European discovery (23andMe, N = 157,485) and the European replication (VisiGen, N = 35,501) 
cohorts. Color codes represent significance in the replication cohort: red = P < 1.04 × 10−3; green = P < 0.05; blue = P > 0.05.
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(41) but also was associated with skin and eye color variation within 
a South Asian population (28, 42). Despite such drastic differences 
in allele frequency for some SNP alleles, the shared eye color effect 
between populations from two different continents demonstrates 
the value of our multiethnic study.
DNA variants identified via GWAS are markers of statistical as­
sociation and not necessarily causative. Because of the differences in 
LD across continental populations, association may not be univer­
sally replicable. Therefore, we next assessed the presence of associa­
tion not just for the lead SNPs in each region but also by testing 
other SNPs located within the 52 genomic regions identified in the 
European discovery analysis. Several SNPs within these regions 
(table ST7) showed evidence for eye color association in both European 
and Asian populations, with genome­wide significance in Europeans 
and suggestive levels of genome­wide association (P < 1 × 10−5) in 
Asians, despite a much smaller sample size. These SNPs also showed 
no significant heterogeneity between the two Asian cohorts. It is 
therefore possible that, against the background of much stronger ef­
fects of European­only alleles or due to population­specific differences 
in MAF, some polymorphisms contributing to European eye color 
variation are also relevant for eye color variability in non­European pop­
ulations, such as variation of brown eye color in Asians tested here.
In Europeans, the 112 autosomal SNPs identified through con­
ditional analysis (all autosomal SNPs shown in table S1) explained 
99.96% (SE = 6.5%, P = 4.8 × 10−279) of the liability scale for blue eyes 
(against brown eyes) and 38.5% (SE = 5.7%, P = 2.2 × 10−130) for inter­
mediate eyes in the TwinsUK cohort, which was one of the VisiGen 
cohorts used for replication. Using the same linear scale as the GWAS 
analysis, these autosomal SNPs explained 53.2% (SE = 4.0%, P = 1.2 × 
10−322) of the total phenotypic variation in eye color in TwinsUK.
Last, we performed in silico analyses to explore the putative func­
tion of the genetic loci our study highlighted with significant eye 
color association using the conditional SNPs. Gene set enrichment 
analysis identified multiple pathways with significant enrichment 
(table ST8). As expected, this included several pigmentation process 
pathways, with “Developmental Pigmentation” the most significant 
(P = 7 × 10−6), followed by “Frizzled Binding” (P = 2.0 × 10−4) and 
“Melanin Metabolic Process” (P = 2.6 × 10−4). We also examined the 
potential effects of the identified eye color–associated SNPs on gene 
expression using data from the GTEx Consortium (43). Despite the 
lack of iris tissue in the GTEx repository, many SNPs showed signif­
icant eQTL (expression quantitative trait loci) effects in multiple cell 
types and tissues (44), as seen for the associated SNPs across 38 (79%) 
of the 48 tissues in the GTEx dataset (table ST9). Most of the strongest 
effects were seen in nerve and sun­exposed skin tissue (P = 8.47 × 10−62 
and P = 4.84 × 10−49, respectively) for rs2835660, where the C allele 
is significantly associated with a decrease in TTC3 expression. TTC3 
is in proximity to DSCR9, a gene whose polymorphisms were previ­
ously associated with eye color (11). These results implicate TTC3 as a 
more likely candidate gene influencing eye color at this genetic locus 
than DSCR9 and that its effect on eye color is likely mediated through 
variation in gene expression. The lack of iris tissue information in 
GTEx likely explains the absence of stronger eQTL effects, such as 
for SNPs with regulatory effects over gene transcription (16).
DISCUSSION
We report the results of the largest GWAS for human eye color to date. 
In addition to confirming the association of SNPs in 11 previously 
known eye color genes (11, 13, 14, 17, 28), the identification of 
50 novel eye color–associated genetic loci helps explain previously 
missing heritability of eye color variability in European populations. 
Moreover, because of the multiethnic design of our study, we 
demonstrate that several of the genetic loci discovered in Europeans 
also have an effect on eye color in Asians.
Eight of the genes in or near the loci newly associated with eye 
color in our study were previously reported for genetic associations 
with other pigmentation traits, such as hair and skin color, for in­
stance, TPCN2, MITF, and DCT (27, 30, 32, 45). The commonality 
of associated DNA variants across the three pigmentation traits 
helps explain why the different pigmentation traits frequently (but 
not completely) intercorrelate in European populations. While many 
significant genetic associations are shared between iris color and 
other pigmentation traits, there are also notable differences. Although 
DNA variants within the MC1R gene are strongly associated with 
light skin and red hair color (27), no detectable association with eye 
color was found in our large GWAS, in line with previous albeit 
smaller­sized GWASs of more limited statistical power (11, 12, 14). 
Similarly, other DNA variants strongly associated with skin and hair 
color within genes, such as SILV, ASIP, and POMC (30), showed no 
statistically significant effect on eye color in this study, nor in previ­
ous studies. Moreover, we also identified 34 genetic loci that were 
significantly associated with eye color, but for which there is no re­
port of significant association with hair and/or skin color. This is 
remarkable as the statistical power of the recent GWASs on hair 
color (31, 46) and sun sensitivity (32) were similar to that of our 
current eye color GWAS. Significant associations for SNPs in/near 
genes involved in iris structure, such as TRAF3IP1 and SEMA3A, 
suggest that they exert their effects with changes in Tyndall scatter­
ing, rather than through alterations of melanin metabolism. Overall, 
this demonstrates that although many genes overlap between eye, 
hair, and skin color, the different human pigmentation traits are not 
completely determined by the same genes as we showed.
The major strengths of our study compared with previous eye 
color GWASs arise from the larger sample size, which translated into 
increased statistical power and also the ability to lower the threshold 
of MAF for which sufficient power to detect association is available. 
Rare SNPs are often a source of considerable phenotypic variation 
(47). For instance, seven (6%) of the independently associated SNPs 
identified by conditional analysis in the discovery cohort had a MAF 
between 0.1 and 1%. Despite their low frequency, however, five (71%) 
of these rare SNPs were in the same region as other, more common 
conditional SNPs that did replicate. The remaining two loci (DAB2 
and an intronic region on chromosome 4) that were not formally 
replicated should therefore be considered only as strong candidates 
with respect to their association with eye color, pending independent 
validation in future studies.
Another strength of this work is the inclusion of European and 
non­European populations. Non­European populations are under­
represented in the GWAS literature in general, including in pigmen­
tation GWASs, but their study is important for the understanding 
of the genetic basis of human phenotypes (48). Although eye color 
variation is typically attributed to individuals of (at least partial) 
European descent, or those originating from areas nearby Europe, 
more subtle variation in brown eyes is also observed in Asian popu­
lations without European admixture (9). Our results from the Asian 
cohorts showed remarkable consistence in the genetic architecture 
of eye color among individuals of different continental ancestries 
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with Asian replication for the two major European genes OCA2 and 
HERC2. Moreover, our findings also suggest that while a single reg­
ulatory variant in HERC2 is responsible for most blue/brown varia­
tion in Europeans (16), many additional DNA variants across both 
OCA2 and HERC2 seem to have independent effects. This hypothesis 
is further supported by our conditional analysis in the European dis­
covery cohort, identifying independent associations spanning ~14 mbp 
across both genes rather than a concentrated cluster centered at 
HERC2 rs1129038. This is remarkable given the large eye color variation 
from the lightest blue to the darkest brown in Europeans, compared 
with the more limited variation within brown eye color in Asians.
In conclusion, our work has identified numerous novel genetic 
loci associated with human eye color in Europeans, of which a sub­
set also shows effects in Asians, despite their largely reduced pheno­
typic eye color variation compared with Europeans. The genetic loci 
we identified explain the majority (53.2%) of eye color phenotypic 
variation (classified using a three­category scale) in Europeans and 
a large proportion of the previously noted missing heritability of eye 
color. Our findings clearly demonstrate that eye color is a genetically 
highly complex human trait, similar to hair (31) and skin color (32), 
as highlighted recently in large European GWASs. The large number 
of novel eye color–associated genetic loci identified here provide a 
valuable resource for future functional studies, aiming to understand 
the molecular mechanisms that explain their eye color association, and 
for future genetic prediction studies, aiming to improve DNA­based 
eye color prediction in anthropological and forensic applications.
METHODS
We performed a GWAS using information from two sources: 157,485 
research participants of European ancestry recruited among the 
customer base of the personal genomics company 23andMe Inc. 
(Sunnyvale, CA, USA) (49) and a meta­analysis of 35,501 European 
individuals from nine populations collected by members of the 
International Visible Trait Genetics (VisiGen) Consortium (45) and 
their study partners. As a secondary analysis and for comparative 
purposes, we included an additional set of 1636 individuals of Asian 




Participants. Participants included for this analysis were 23andMe 
consumers who consented to participate in research and were deter­
mined to have greater than 97% European ancestry using genotype 
clustering. A segmented identity­by­descent algorithm (50) was then 
applied to obtain the maximal subset (157,485) of unrelated indi­
viduals to be used as our discovery cohort (full details on ancestry 
and relatedness calculations are provided in the Supplementary 
Methods, and principal component plots are provided in fig. S2).
Genotyping. Participants were genotyped on one of 23andMe’s 
own custom­designed SNP arrays. The V4 platform is a fully cus­
tomized array containing a subset of SNPs from previous versions, 
while the V3 is a customized platform based on the OmniExpress+ 
BeadChip, and the V1 and V2 platforms are customized variants of 
the Illumina HumanHap550+ BeadChip (full descriptions of plat­
forms and genotyping procedure are provided in the Supplementary 
Methods). Imputation of additional variants was completed using 
1000 Genomes phase 1 as reference haplotypes (51).
Phenotyping. Phenotyping for iris color in this cohort was derived 
from questionnaires. Participants were asked to self­categorize eye 
color into one of seven distinct groups ranging from blue to dark 
brown based on color matching (full details are provided in the 
Supplementary Methods). This categorization allowed greater pheno­
typic resolution than previous three­color categories while main­
taining groups distinctive enough to reduce misclassification. These 
groups were converted into a numerical scale ranging from 0 (blue) 
to 6 (dark brown) and used as the outcome variable for linear 
regression–based GWAS analysis.
VisiGen consortium and study partners
Participants. Specific recruitment criteria varied for each cohort (Sup­
plementary Materials), with participants from the United Kingdom, 
The Netherlands, Italy, and European descendants in the United 
States and Australia.
Principal components analyses examined the genetic ancestry for 
each cohort and confirmed each was of nonadmixed European 
ancestry (specific details for each cohort are provided in the Supple­
mentary Methods).
Phenotyping. Eye color categorization varied between cohorts, 
with most of the European cohorts adopting a 3­ or 5­point categor­
ical scale (details for each cohorts’ classification are provided in the 
Supplementary Methods).
Singaporean cohorts
Participants. Full GWAS summary statistics were available for 
959 participants of Chinese descent recruited at the Singapore 
Polyclinic and for 677 participants in the Singapore Indian Eye 
Study (SINDI).
Phenotyping. Phenotypes in these cohorts were ascertained using 
image analysis of digital photographs, better suited to capture vari­
ation within these populations (full details are provided in the Sup­
plementary Methods).
Statistical analyses
Association tests. We performed an independent linear regression 
for each cohort under the assumption of an additive model for allelic 
effects, with adjustments made for age, sex, and the first five principal 
components. Adjustment was made also for the genotyping platform 
(V1 to V4), and additional measures controlling for relatedness were 
implemented for the VisiGen family cohorts (full details for each 
cohort are provided in the Supplementary Methods). The use of a 
linear scale may be limited by the assumption that there is an equal 
difference between each group; however, as eye color phenotypically 
follows linear scale across the color spectrum, this choice of statisti­
cal model is appropriate and in accordance with previous studies on 
eye color (11, 27, 49).
Meta-analyses. The QC’ed summary statistics from the VisiGen 
and Singaporean cohorts were pooled into two separate meta­analyses: 
the first was conducted using data from the nine VisiGen European 
cohorts, and the second using data from the two Singaporean co­
horts. Both meta­analyses were performed using METAL (52) ap­
plying a weighted Z­score approach, given the differing phenotypic 
scales used across individual cohorts, with genomic control adjust­
ments (24) made for the VisiGen meta­analysis (see the Supplementary 
Methods). A final meta­analysis was then conducted between the 
23andMe cohort and the European VisiGen cohorts following the 
same procedures with a weighted Z score approach and genomic 
control adjustments.
Definition of genomic region and significance. We adopted the cus­
tomary definition for a GWAS significance threshold of 5 × 10−08. 
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For this work, an “associated region” was a genomic region demar­
cated by consecutive significantly associated genomic markers, sep­
arated by a nonassociated region greater than 1 million base pairs.
LD score regression. LD Hub (53) was used to perform LD score 
regression (25) on the summary statistics from our GWASs to test 
for possible inflation. This method is more suited to our study than 
the Devlin (24) genomic inflation lambda because of high trait poly­
genicity and the large cohort sizes (25).
Conditional analysis. Conditional analysis was conducted using 
summary statistics with genome­wide complex trait analysis (GCTA) 
(54) following the same procedure described by Yang et al. (55). 
Genotypic data from unrelated participants in TwinsUK were used 
as a reference for LD structure, a distance of 1000 kb was set as an 
assumption of complete linkage equilibrium, and a collinearity 
threshold was set at R2 > 0.9.
Variant effect prediction. The predicted effects of variants were 
performed using the Ensembl Variant Effect Predictor (VEP) (37).
Heritability explained by the independent SNPs. Population lia­
bility scale heritability (56) explained by associated SNPs identified 
in the 23andMe discovery cohort was calculated using an unrelated 
sample from the TwinsUK cohort using restricted maximum likeli­
hood analysis (54) under the assumption that the population prev­
alence (taken from the 23andMe cohort) is 30.3% for blue eyes and 
38.3% for intermediate colors.
Pathway analysis. Genetic pathway analysis for iris color was per­
formed with MAGENTA (57) using the 23andMe discovery SNP 
association results as input (full details are provided in the Supple­
mentary Methods). Gene set definitions defined by Gene Ontology 
(58) were obtained from the Molecular Signatures Database (version 
MSigDB v6.1) (59) for this analysis.
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